[Back to Number 6 ToC] [Back to Journal Contents] [Back to Biokhimiya Home page]

Expression of NMDA Neuroreceptors in Experimental Ischemia

M. U. Gappoeva*, G. A. Izykenova, O. K. Granstrem, and S. A. Dambinova

Department of Neurology and Neurosurgery, Pavlov State Medical University, ul. Tolstogo 6/8, St. Petersburg, Russia; E-mail: gappoeva@mail.ru; gizyken@aol.com

* To whom correspondence should be addressed.

Received March 22, 2002; Revision received June 25, 2002
The role of NMDA receptors in molecular mechanisms of neurotoxicity was investigated using rat models of global and focal cerebral ischemia. Expression of NR2A and NR2B receptor mRNAs up-regulated in cortex after 3 h of reperfusion following middle cerebral artery occlusion (MCAo). This effect was accompanied by an increase in NR2A and NR2B immunoreactivity. At six hours of reperfusion, drastic activation of NR2A mRNA expression was observed in the penumbra that returned to the control level at 24 h of reperfusion. The monitoring of NR2A autoantibodies in the blood of the experimental rats showed its reliable increase to the 5-6th day of reperfusion that maintained elevated to the 20th day of the experiment. The data indicate that NR2A and 2B receptor subunits and NR2A autoantibodies are biochemical markers of the neurotoxicity underlying cerebral ischemia.
KEY WORDS: neurotoxicity, NR2-NMDA receptors, RT-PCR, autoantibodies